Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A van Hogezand

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
The Netherlands Journal of Medicine|August 1, 1994
Medical management of patients with difficult-to-treat inflammatory bowel diseaseR A van Hogezand
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1988
Pharmacokinetics of olsalazine and its metabolitesR A van Hogezand
Nederlands Tijdschrift Voor Geneeskunde|December 17, 1994
[Possibilities of drug treatment in inflammatory intestinal diseases]R A van Hogezand, C B Lamers
The Netherlands Journal of Medicine|January 12, 1999
Management of recurrent Crohn's diseaseR A van Hogezand, W A Bemelman
The Netherlands Journal of Medicine|February 1, 1996
Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?R A van Hogezand, H W Verspaget
Drugs|October 20, 1998
The future role of anti-tumour necrosis factor-alpha products in the treatment of Crohn's diseaseR A van Hogezand, H W Verspaget
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1997
New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapyR A van Hogezand, H W Verspaget
Scandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Skeletal morbidity in inflammatory bowel diseaseR A van Hogezand, N A T Hamdy
Nederlands Tijdschrift Voor Geneeskunde|December 29, 1998
[Unconventional imaging techniques in inflammatory bowel diseases]M N Wasser, J Stoker, R A van Hogezand, et al.
Scandinavian Journal of Gastroenterology. Supplement|September 28, 1999
Azathioprine: an update on clinical efficacy and safety in inflammatory bowel diseaseC B Lamers, G Griffioen, R A van Hogezand, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
The Netherlands Journal of Medicine|August 1, 1994
Medical management of patients with difficult-to-treat inflammatory bowel diseaseR A van Hogezand
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1988
Pharmacokinetics of olsalazine and its metabolitesR A van Hogezand
Nederlands Tijdschrift Voor Geneeskunde|December 17, 1994
[Possibilities of drug treatment in inflammatory intestinal diseases]R A van Hogezand, C B Lamers
The Netherlands Journal of Medicine|January 12, 1999
Management of recurrent Crohn's diseaseR A van Hogezand, W A Bemelman
The Netherlands Journal of Medicine|February 1, 1996
Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?R A van Hogezand, H W Verspaget
Drugs|October 20, 1998
The future role of anti-tumour necrosis factor-alpha products in the treatment of Crohn's diseaseR A van Hogezand, H W Verspaget
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1997
New therapies for inflammatory bowel disease: an update on chimeric anti-TNF alpha antibodies and IL-10 therapyR A van Hogezand, H W Verspaget
Scandinavian Journal of Gastroenterology. Supplement|June 20, 2006
Skeletal morbidity in inflammatory bowel diseaseR A van Hogezand, N A T Hamdy
Nederlands Tijdschrift Voor Geneeskunde|December 29, 1998
[Unconventional imaging techniques in inflammatory bowel diseases]M N Wasser, J Stoker, R A van Hogezand, et al.
Scandinavian Journal of Gastroenterology. Supplement|September 28, 1999
Azathioprine: an update on clinical efficacy and safety in inflammatory bowel diseaseC B Lamers, G Griffioen, R A van Hogezand, et al.
Pageof 7